Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 2/3 1Phase 1 1

Status

Active not recruiting 4Recruiting 2

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 72Colorectal Neoplasms 43Rectal Neoplasms 41Stomach Neoplasms 38Triple Negative Breast Neoplasms 30Neoplasm Metastasis 19Esophageal Neoplasms 16Colonic Neoplasms 16Pancreatic Neoplasms 12Parkinson Disease 4, Autosomal Dominant Lewy Body 11Neoplasms 11Nasopharyngeal Carcinoma 11Adenocarcinoma 11Biliary Tract Neoplasms 10Adenocarcinoma Of Esophagus 9Cholangiocarcinoma 7Locally Advanced Rectal Cancer 6Esophageal Squamous Cell Carcinoma 6Brain Neoplasms 6Anus Neoplasms 6Recurrence 5Gastrointestinal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neuroendocrine Tumors 4HER2-positive Breast Cancer 4Colorectal Cancer Metastatic 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Pathologic Complete Response 3Ovarian Neoplasms 3

Interventions

pembrolizumab 7Nivolumab 7Specimen Handling 6Mitomycin 6Magnetic Resonance Spectroscopy 6Capecitabine 6Radiotherapy 5Fluorouracil 4Drug Therapy 4Biopsy 4Radiation 3Paclitaxel 3Ipilimumab 3Fluorodeoxyglucose F18 3Carboplatin 3dehydroftorafur 2atezolizumab 2aldesleukin 2Tomography, X-Ray Computed 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Proctoscopy 2Mitozytrex 2Colonoscopy 2CTLA-4 Antigen 2Adoptive Transfer 2trastuzumab deruxtecan 1spartalizumab 1enzalutamide 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Anus Neoplasms × Capecitabine × 1 year × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT04166318 2026-05-05

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
252 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT05838391 2026-02-03

Adaptive Radiation in Anal Cancer

Columbia University

Phase NA Recruiting
20 enrolled
Gastrointestinal

Anus Neoplasms

NCT05902533 2025-12-18

REDEL

University of Cincinnati

Phase 2/3 Active not recruiting
33 enrolled
Gastrointestinal

Anus Neoplasms

NCT06207981 2025-09-02

KANALRAD

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting
310 enrolled
Gastrointestinal

Anus Neoplasms

NCT04046133 2025-08-05

CORINTH

Cardiff University

Phase 1 Active not recruiting
52 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡